Oncologix Tech Inc.: 10-Q filed 2013-04-15

Name: Oncologix Tech Inc.: 10-Q filed 2013-04-15
Creator: Oncologix Tech Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Oncologix Tech Inc. reported in its quarterly report filed 2013-04-15 (fiscal Q2 2013): 23 published measures, 64 facts as tagged in accession 0001000096-13-000047.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-04-15
Fiscal period: fiscal Q2 2013
Accession: 0001000096-13-000047 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Oncologix Tech Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-02-28	10,712	USD
At 2012-08-31	6,405	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-02-28	638,303	USD
At 2012-08-31	593,806	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-02-28	-627,591	USD
At 2012-08-31	-587,401	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-02-28	72	USD
At 2012-08-31	1,931	USD
At 2012-02-29	6,863	USD
At 2011-08-31	11,067	USD
At 2011-05-31	3,799	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-09-01 to 2013-02-28	-100,673	USD	181
2011-06-01 to 2013-02-28	-434,672	USD	639
2011-09-01 to 2012-02-29	-188,058	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-09-01 to 2013-02-28	-47,748	USD	181
2011-06-01 to 2013-02-28	-234,158	USD	639
2011-09-01 to 2012-02-29	-64,004	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-06-01 to 2013-02-28	1,289	USD	639
2011-09-01 to 2012-02-29	1,677	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-06-01 to 2013-02-28	-1,289	USD	639
2011-09-01 to 2012-02-29	-1,677	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-02-28	-58,004,869	USD
At 2012-08-31	-58,004,869	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-02-28	1,301	USD
At 2012-08-31	1,481	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-09-01 to 2012-02-29	10,000	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-12-01 to 2013-02-28	-36,807	USD	90
2012-09-01 to 2013-02-28	-80,647	USD	181
2011-06-01 to 2013-02-28	-246,408	USD	639
2011-12-01 to 2012-02-29	-32,750	USD	91
2011-09-01 to 2012-02-29	-69,470	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-02-28	9,411	USD
At 2012-08-31	4,924	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-02-28	638,303	USD
At 2012-08-31	233,781	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-12-01 to 2013-02-28	36,807	USD	90
2012-09-01 to 2013-02-28	80,647	USD	181
2011-06-01 to 2013-02-28	246,408	USD	639
2011-12-01 to 2012-02-29	32,750	USD	91
2011-09-01 to 2012-02-29	69,470	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-02-28	61,587,422	shares
At 2012-08-31	57,563,258	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-02-28	57,753,692	USD
At 2012-08-31	57,697,233	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2013-02-28	25,812	USD
At 2012-08-31	25,812	USD
At 2011-08-31	25,812	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-02-28	9,006	USD
At 2012-08-31	8,916	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-02-28	9,339	USD
At 2012-08-31	2,993	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-12-01 to 2013-02-28	-53,726	USD	90
2012-09-01 to 2013-02-28	-100,666	USD	181
2011-06-01 to 2013-02-28	-434,648	USD	639
2011-12-01 to 2012-02-29	-43,213	USD	91
2011-09-01 to 2012-02-29	-188,052	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-12-01 to 2013-02-28	36,717	USD	90
2012-09-01 to 2013-02-28	80,467	USD	181
2011-06-01 to 2013-02-28	245,262	USD	639
2011-12-01 to 2012-02-29	32,566	USD	91
2011-09-01 to 2012-02-29	69,210	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-09-01 to 2013-02-28	40,000	USD	181
2011-06-01 to 2013-02-28	215,000	USD	639
2011-09-01 to 2012-02-29	65,000	USD	182

Inspect the source

Entity: Oncologix Tech Inc. / CIK 0000799694
Captured: 2026-09-23 02:40 UTC
SEC response SHA-256: acc83506e9d3f32d85d91503a2bd087a712fbc014fe7429b835fa6f76c6de48d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000799694.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))